I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients
This is an open label, single arm, multicenter, phase Ib study to evaluate the safety and clinical activity of the combination of ipatasertib, trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic HER2-positive breast cancer with tumors harboring PIK3CA mutations, candidates to receive maintenance HP after first line …
adenocarcinoma of the breast
trastuzumab
progressive disease
pertuzumab
serum bilirubin
- 0 views
- 19 Feb, 2024